120 related articles for article (PubMed ID: 38664889)
1. Central sensitivity syndrome affects the disease activity index and treatment satisfaction in patients with rheumatoid arthritis.
Seki K; Imagama T; Seki T; Okazaki T; Sakai T
Int J Rheum Dis; 2024 Apr; 27(4):e15159. PubMed ID: 38664889
[TBL] [Abstract][Full Text] [Related]
2. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
Yoshii I; Chijiwa T; Sawada N
Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
[TBL] [Abstract][Full Text] [Related]
3. Association Between Pain Sensitization and Disease Activity in Patients With Rheumatoid Arthritis: A Cross-Sectional Study.
Lee YC; Bingham CO; Edwards RR; Marder W; Phillips K; Bolster MB; Clauw DJ; Moreland LW; Lu B; Wohlfahrt A; Zhang Z; Neogi T
Arthritis Care Res (Hoboken); 2018 Feb; 70(2):197-204. PubMed ID: 28437846
[TBL] [Abstract][Full Text] [Related]
4. Extraarticular manifestations in Turkish patients with rheumatoid arthritis: impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.
Eser F; Garip Y; Bodur H
Rheumatol Int; 2012 Jun; 32(6):1521-5. PubMed ID: 21327425
[TBL] [Abstract][Full Text] [Related]
5. How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments.
Noda K; Saitou M; Matsushita T; Ukichi T; Kurosaka D
Clin Exp Rheumatol; 2022 Nov; 40(11):2119-2124. PubMed ID: 35200132
[TBL] [Abstract][Full Text] [Related]
6. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
[TBL] [Abstract][Full Text] [Related]
7. Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
Saitou M; Noda K; Matsushita T; Ukichi T; Kurosaka D
Clin Exp Rheumatol; 2022 May; 40(5):980-987. PubMed ID: 34128802
[TBL] [Abstract][Full Text] [Related]
8. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
9. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
Markenson JA; Koenig AS; Feng JY; Chaudhari S; Zack DJ; Collier D; Weaver A
J Clin Rheumatol; 2013 Sep; 19(6):317-23. PubMed ID: 23965479
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
[TBL] [Abstract][Full Text] [Related]
11. Direct and Indirect Determinants of the Patient Global Assessment in Rheumatoid Arthritis: Differences by Level of Disease Activity.
Ward MM; Guthrie LC; Dasgupta A
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):323-329. PubMed ID: 27273981
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
Melikoglu MA; Ataman S; Bodur H; Cay HF; Capkin E; Akgul O; Cevik R; Gogus F; Kamanli A; Yurdakul FG; Gurer G; Yagci I; Rezvani A; Duruoz MT; Sunar I
Rheumatol Int; 2021 Nov; 41(11):1971-1978. PubMed ID: 34559275
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
[TBL] [Abstract][Full Text] [Related]
14. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis.
Salaffi F; Ciapetti A; Gasparini S; Migliore A; Scarpellini M; Corsaro SM; Laganà B; Mozzani F; Varcasia G; Pusceddu M; Castriotta M; Serale F; Maier A; Foti R; Scarpa R; Bombardieri S;
Clin Exp Rheumatol; 2010; 28(6):855-65. PubMed ID: 21122262
[TBL] [Abstract][Full Text] [Related]
16. Different wording of the Patient Global Visual Analogue Scale (PG-VAS) affects rheumatoid arthritis patients' scoring and the overall Disease Activity Score (DAS28): a cross-sectional study.
French T; Hewlett S; Kirwan J; Sanderson T
Musculoskeletal Care; 2013 Dec; 11(4):229-37. PubMed ID: 23378146
[TBL] [Abstract][Full Text] [Related]
17. Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
Strand V; Kaine J; Alten R; Wallenstein G; Diehl A; Shi H; Germino R; Murray CW
Arthritis Res Ther; 2020 Oct; 22(1):243. PubMed ID: 33059710
[TBL] [Abstract][Full Text] [Related]
18. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
Curtis JR; Yang S; Chen L; Pope JE; Keystone EC; Haraoui B; Boire G; Thorne JC; Tin D; Hitchon CA; Bingham CO; Bykerk VP
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1345-53. PubMed ID: 25988705
[TBL] [Abstract][Full Text] [Related]
19. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
Neblett R; Hartzell MM; Mayer TG; Cohen H; Gatchel RJ
Pain Pract; 2017 Feb; 17(2):166-175. PubMed ID: 26989894
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
